Health
Pfizer to Seek FDA Approval for COVID-19 Vaccine After Election – Latin Post
Pfizer said their company will not ask for Food and Drug Administration (FDA) approval for their COVID-19 vaccine candidate until after the election.
Pfizer said their company will not ask for Food and Drug Administration (FDA) approval for their COVID-19 vaccine candidate until after the election.
As Pfizer CEO Albert Bourla said in an open letter, their COVID-19 vaccine cannot request for emergency FDA approval before the third week of November.
The timeline is only based on Pfizer’s best estimates and does not account for delays on the COVID-19 vaccine, said an Associated Press report.
Bourla said that if they do ask for FDA approval, t…
-
General7 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business6 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General9 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News9 hours agoSurgeon partner of former premier to testify over his patient’s death